Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-13-003914
Filing Date
2013-09-10
Accepted
2013-09-10 09:46:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 filing.txt SC 13G/A 8520
  Complete submission text file 0000315066-13-003914.txt   10108
Mailing Address 245 SUMMER STREET BOSTON MA 02210
Business Address 245 SUMMER STREET BOSTON MA 02210 6175706339
FMR LLC (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 061209781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45955 | Film No.: 131087057
SIC: 2836 Biological Products, (No Diagnostic Substances)